Amedeo Smart

Free Medical Literature Service


 

Amedeo

Head and Neck Cancer

  Free Subscription

17.11.2025

3 Am J Surg
3 BMC Cancer
2 Dis Esophagus
2 Histopathology
1 Hum Pathol
1 Int J Cancer
15 Oral Oncol
1 Otolaryngol Head Neck Surg
2 PLoS One
3 Radiother Oncol
2 Thyroid



    Am J Surg

  1. SONG Z, Akund R, Wu C, Fazendin J, et al
    Performance of molecular testing for indeterminate thyroid nodules in Black patients.
    Am J Surg. 2025;250:116569.
    >> Share

  2. LUI MS, Hangge PT, DeLozier O, Patel KN, et al
    More than just stuck in the middle: papillary thyroid cancer of the isthmus may present with aggressive features and nodal metasasis.
    Am J Surg. 2025;250:116621.
    >> Share

  3. LIOU R, Slattery L, Hu Y, Kuo EJ, et al
    Short-term outcomes in radiofrequency ablation for the primary treatment of T1N0M0 papillary thyroid carcinomas.
    Am J Surg. 2025 Oct 31:116702. doi: 10.1016/j.amjsurg.2025.116702.
    >> Share


    BMC Cancer

  4. EROGLU I, Mohring C, Sadeghlar F, Manczak A, et al
    Efficacy and safety of neoadjuvant FLOT treatment for resectable gastric/gastroesophageal junction adenocarcinoma in Turkish and German patients; a real-world data.
    BMC Cancer. 2025;25:1754.
    >> Share

  5. YANG P, Liu S, Chen X, Xin H, et al
    Muscle-specific MRI grading of soft tissue involvement provides additional prognostic value beyond skull base criteria in nasopharyngeal carcinoma: a retrospective study.
    BMC Cancer. 2025;25:1751.
    >> Share

  6. PENG Y, Huang K, Gong Z, Liu W, et al
    Nonenhanced CT-Based radiomics model enhances PTC detection in Hashimoto's thyroiditis.
    BMC Cancer. 2025;25:1760.
    >> Share


    Dis Esophagus

  7. TOSHIYAMA S, Honda M, Murakami M, Kikuchi Y, et al
    Proton beam-based chemoradiotherapy versus surgery plus adjuvant chemotherapy for esophageal squamous cell carcinoma: a comparison of the long-term survival from a single-center cohort study.
    Dis Esophagus. 2025;38:doaf099.
    >> Share

  8. JONES DG, Grimminger P, Reynolds J, Rosati R, et al
    Toward standardization in esophageal cancer surgery: patterns of practice across high-volume European centers.
    Dis Esophagus. 2025;38:doaf100.
    >> Share


    Histopathology

  9. SUN M, Fu L, Ren H, Wang J, et al
    Two similar but distinct types of breast acinar cell carcinoma: evidence from histological, immunohistochemical and molecular features.
    Histopathology. 2025;87:904-914.
    >> Share

  10. BELL PD, Kaul V, Bittner KM, Chen IY, et al
    Margin clearance and post-procedure ablation decrease recurrence risk in endoscopic mucosal resections for Barrett's-related neoplasia.
    Histopathology. 2025;87:856-868.
    >> Share


    Hum Pathol

  11. BEDELL M, Skaugen JM, Nikiforov Y, Reyes-Mugica M, et al
    Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in the adolescent and young adult population: A pediatric center experience.
    Hum Pathol. 2025;165:105951.
    >> Share


    Int J Cancer

  12. WANG Y, Xi Y, Qiao L, Yu Y, et al
    Ethnic, sex, and age disparities in esophageal cancer and medical costs: A population-based study of 18 million people in China.
    Int J Cancer. 2025 Nov 11. doi: 10.1002/ijc.70236.
    >> Share


    Oral Oncol

  13. VAN LOOCKE P, Beuselinck B, Meulemans J, Nuyts S, et al
    Impact of time-of-day administration of immune checkpoint inhibitors on survival outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC): a retrospective cohort study.
    Oral Oncol. 2025;171:107772.
    >> Share

  14. DIEZ-FRAILE A, Pottel L, Lamoral P, De Backer T, et al
    Age and surgical complexity outperform preoperative Geriatric-8 for 30-day major complications in older head and neck cancer.
    Oral Oncol. 2025;171:107774.
    >> Share

  15. DOERFLER R, Chen J, Kim C, Smith JD, et al
    Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer.
    Oral Oncol. 2025;171:107742.
    >> Share

  16. OKURA M, Yamakawa N, Otsuru M, Hasegawa T, et al
    T4a classification for oral cancer using mandibular canal invasion instead of bone marrow invasion in the TNM staging system.
    Oral Oncol. 2025;171:107771.
    >> Share

  17. ZHANG Y, Liu Z, Wu C, Li G, et al
    Determination of the pathological staging of the oral squamous cell carcinoma based on microscopic hyperspectral imaging.
    Oral Oncol. 2025;170:107686.
    >> Share

  18. ZHANG Q, Luo X, Fu M, Peng B, et al
    Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma.
    Oral Oncol. 2025;170:107695.
    >> Share

  19. GONG J, Han B, Tang X, Men Y, et al
    Intraoral microvascular anastomosis: A minimally invasive technique for lateral arm free flap tongue reconstruction.
    Oral Oncol. 2025;170:107656.
    >> Share

  20. PALATNIK B, Kazadi D, Jethwa A, Nelson A, et al
    Genomic evolution of a metastatic oral squamous cell carcinoma: a case report, molecular analysis, and review of the literature.
    Oral Oncol. 2025;170:107734.
    >> Share

  21. MARUDHUPANDI T
    Letter to the Editor: Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma.
    Oral Oncol. 2025;170:107740.
    >> Share

  22. HE X, Xu Y, Ren Y, Wang J, et al
    Neoadjuvant chemotherapy combined with anti-PD-1 monoclonal antibody in locally advanced resectable oral squamous cell carcinoma: efficacy evaluation and prediction.
    Oral Oncol. 2025;170:107744.
    >> Share

  23. MARUDHUPANDI T
    Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2025;170:107746.
    >> Share

  24. LI R, Ma S, Tang T, Zhao Y, et al
    Prognostic impact and risk factors of level IV/V lymph nodes metastasis in laryngeal squamous cell carcinoma.
    Oral Oncol. 2025;170:107758.
    >> Share

  25. ZHAO P, Shen Q, Wang J, Chen Y, et al
    Prognostic factors of head and neck osteosarcoma: A 10-year retrospective study from a single institute.
    Oral Oncol. 2025;170:107759.
    >> Share

  26. MARUDHUPANDI T
    Letter to the Editor: Developing a predictive nomogram model for incidence of adverse outcomes in oral and maxillofacial tumor patients undergoing free flap reconstruction.
    Oral Oncol. 2025;170:107751.
    >> Share

  27. WILLIAMS MM, Hanna GJ, Sethi RK, Rettig EM, et al
    Outcomes of oropharyngeal squamous cell carcinoma among patients with lymphoproliferative disorders.
    Oral Oncol. 2025;170:107761.
    >> Share


    Otolaryngol Head Neck Surg

  28. ROSEN R, Richter J, Cabrera CI, Karasik D, et al
    Long-Term Opioid Use After Treatment of Head and Neck Cancers: A Systematic Review and Meta-analysis.
    Otolaryngol Head Neck Surg. 2025 Nov 12. doi: 10.1002/ohn.70024.
    >> Share


    PLoS One

  29. LABOREY M, Lajoinie A, Freilich J, Samalin E, et al
    Methodological approach to optimize a step-by-step deterministic linkage of SNDS data with a clinical database (FREGAT) of gastric/gastroesophageal junction adenocarcinoma in France: Pitfalls and learnings.
    PLoS One. 2025;20:e0333667.
    >> Share

  30. CHOI YK, Son SH, Jang HS, Kim IH, et al
    Prognostic role of effective radiation dose to immune cells in esophageal cancer treated with definitive chemoradiation.
    PLoS One. 2025;20:e0336794.
    >> Share


    Radiother Oncol

  31. VISCHIONI B, Bonora M, Fontana G, Scardo S, et al
    Prognostic factors and clinical outcomes in a large cohort of head and neck adenoid cystic carcinoma patients treated with proton beam therapy: Insights from an Italian referral center.
    Radiother Oncol. 2025;213:111143.
    >> Share

  32. ALYAMANI N, Abrunhosa-Branquinho A, Corning C, Sharabiani M, et al
    Radiotherapy quality assurance of the prospective randomised EORTC-1219/DAHANCA-29 trial: an individual case review analysis.
    Radiother Oncol. 2025;213:111141.
    >> Share

  33. JIANG W, Xiao Y, Hu H, Li J, et al
    Postoperative Intensity-Modulated radiotherapy with trigeminal nerve pathway delineation for head and neck adenoid cystic carcinoma.
    Radiother Oncol. 2025;213:111174.
    >> Share


    Thyroid

  34. VAN DE BERG DJ, Vriens MR, van Santen HM, Seur A, et al
    Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi Study.
    Thyroid. 2025 Nov 7. doi: 10.1177/10507256251390871.
    >> Share

  35. SCHONEBAUM LE, Oudijk L, Stegenga MT, Bramer WM, et al
    The Prognostic Value of Immunohistochemical Biomarkers in Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
    Thyroid. 2025 Nov 6. doi: 10.1177/10507256251393208.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016